Some autoimmune diseases are different in women and men. A group of researchers from the Chinese Academy of Sciences (CAS) has found a strong female bias in the response of a neurotransmitter receptor ...

Intra-Cellular Therapies Inc. has patented compounds acting as serotonin transporter (SERT), 5-HT2A, dopamine D1 and D2 receptor ligands reported to be useful for the treatment of neurological ...

On the same day that some Parkinson’s disease drugs are being called into question, AbbVie has announced that its late-stage monotherapy candidate has significantly reduced the burden of the disease ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

The bipolar disorder clinical trial landscape is evolving with 25+ therapies, namely, KarXT (BMS), RAP 219 (Rapport Therapeutics), ABBV-932 (AbbVie Inc.), ABX-002 (Autobahn Therapeutics), ALTO-100 ...

Ever get that little rush of excitement when someone likes your post or follows you on social media? That's dopamine kicking into action. Dopamine is a feel-good neurotransmitter that involves ...